Search results
Results from the WOW.Com Content Network
UTRECHT, The Netherlands and CAMBRIDGE, Mass., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics®) and Partner Therapeutics, Inc. (PTx), a private, fully-integrated biotechnology company with a focus in hematology and oncology ...
On February 1, 2018, Partner Therapeutics, Inc. acquired the global rights to develop, manufacture, and commercialize Leukine (sargramostim) from Sanofi. [ 13 ] References
Molecular Partners AG is a clinical-stage biopharmaceutical company based in Zürich, Switzerland. [2] The company is developing a new class of potent, specific and versatile small-protein therapies called DARPins, [3] with potential clinical applications in a range of disease areas including oncology, immuno-oncology, ophthalmology, and infectious diseases.
This is a list of large or well-known interstate or international companies headquartered in the Seattle metropolitan area.. As of December 2021, the Seattle metropolitan area is home to ten Fortune 500 companies: Internet retailer Amazon (#2), Costco Wholesale (#12), Microsoft (#15), coffee chain Starbucks (#125), Paccar (#159), clothing merchant Nordstrom (#289), Weyerhaeuser (#387 ...
2012 – Mallinckrodt announced acquisition of CNS Therapeutics for $100 million [66] 2013 – Mallinckrodt spun off from Covidien and began trading under ticker symbol MNK [2] 2013 – Mallinckrodt acquired Cadence Pharmaceuticals for £1.3 billion in an Irish corporate tax inversion to escape U.S. taxes. [67] [68]
GTx, Inc. was a pharmaceutical company working on drugs in the selective estrogen receptor modulator (SERM) and selective androgen receptor modulator (SARM) classes. Its drugs in development included enobosarm (ostarine) and GTx-758.
Puma was founded in September 2010 by Alan Auerbach to identify and in-license compounds that were already in clinical development. [2] This was the same business plan Auerbach had followed at Cougar Biotechnology, which he founded in 2003, and through which he in-licensed abiraterone acetate from BTG plc. [2]
Schrödinger's partners include pharmaceutical companies, including Bayer, [6] [7] Takeda, [8] and more.. Nimbus Therapeutics, co-founded by Schrödinger, uses Schrödinger's drug screening and design platform for drug discovery.